Latest news, press releases, and SEC filings for Grace Therapeutics, Inc (GRCE) https://caymanjournal.com/stock/GRCE en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 21:38:31 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 📄 What This Document Is This is an 8-K filing, which companies use to announce major news to investors. Here, Grace Therapeutics is sharing that the FDA rejected their initial application for a new drug called GTx-104. It’s not a final "no," but a "not yet" — a Complete Response Letter (CRL) sayi https://caymanjournal.com/stock/GRCE/sec-filing/0001140361-26-016324 https://caymanjournal.com/stock/GRCE/sec-filing/0001140361-26-016324 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing